Our results suggest that this activity might be associated to the ability of DYRK3 to interact with and phosphorylate CAMKV, a protein abundantly expressed in high-risk NB and—like DYRK3—strongly correlated to a worse patient survival probability. This evidence concerns the gene CAMKV and neuroblastoma.